Metropolitan Life Insurance Company (MetLife)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,353
| Closed | -$89.6K | – | 1139 |
|
|
2024
Q1 | $89.6K | Sell |
1,353
-71
| -5% | -$4.7K | ﹤0.01% | 1103 |
|
|
2023
Q4 | $56.6K | Hold |
1,424
| – | – | ﹤0.01% | 1381 |
|
|
2023
Q3 | $45.4K | Buy |
1,424
+192
| +16% | +$6.12K | ﹤0.01% | 1457 |
|
|
2023
Q2 | $49.5K | Buy |
1,232
+190
| +18% | +$7.63K | ﹤0.01% | 1420 |
|
|
2023
Q1 | $44.5K | Sell |
1,042
-149
| -13% | -$6.36K | ﹤0.01% | 1452 |
|
|
2022
Q4 | $57.2K | Buy |
1,191
+108
| +10% | +$5.19K | ﹤0.01% | 1389 |
|
|
2022
Q3 | $40.7K | Hold |
1,083
| – | – | ﹤0.01% | 1599 |
|
|
2022
Q2 | $29.9K | Hold |
1,083
| – | – | ﹤0.01% | 1821 |
|
|
2022
Q1 | $58.9K | Sell |
1,083
-2,999
| -73% | -$163K | ﹤0.01% | 1503 |
|
|
2021
Q4 | $239K | Hold |
4,082
| – | – | ﹤0.01% | 1903 |
|
|
2021
Q3 | $161K | Hold |
4,082
| – | – | ﹤0.01% | 2246 |
|
|
2021
Q2 | $173K | Buy |
4,082
+270
| +7% | +$11.5K | ﹤0.01% | 2253 |
|
|
2021
Q1 | $235K | Hold |
3,812
| – | – | ﹤0.01% | 1910 |
|
|
2020
Q4 | $269K | Buy |
3,812
+1,181
| +45% | +$83.3K | ﹤0.01% | 1739 |
|
|
2020
Q3 | $101K | Hold |
2,631
| – | – | ﹤0.01% | 2213 |
|
|
2020
Q2 | $98.7K | Buy |
+2,631
| New | +$98.7K | ﹤0.01% | 2262 |
|